Double-blind, parallel-group, controlled Phase 3 study of MRA in rheumatoid arthritis(RA)
Latest Information Update: 17 Jun 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 17 Jun 2016 New trial record